Hemodialysis Vascular Access Complications: A 12-Month Comparative Study of Arteriovenous Fistulas and Central Venous Catheters

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/ebfc8725c111cc357c68e2fde585a072.pdf
Hemodialysis Vascular Access Complications: A 12-Month Comparative Study of Arteriovenous Fistulas and Central Venous Catheters

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
NADA
NECIB
NADA NECIB nada.necib@diaverum.com DIAVERUM DIALYSIS MONTERAU FAULT YONNE France *
SAMIR ALBITAR samir.albitar@diaverum.com DIAVERUM DIALYSIS MONTERAU FAULT YONNE France -
-
-
-
-
-
-
-
-
-
-
-
-
-

Vascular access is pivotal to hemodialysis adequacy and patient survival. Arteriovenous fistulas (AVFs) are preferred for long-term use, while central venous catheters (CVCs) are associated with higher morbidity and complication rates. This study compared 12-month vascular access complications between AVF and CVC users in a single hemodialysis center in France.

We retrospectively analyzed 100 adult patients receiving maintenance hemodialysis between 2024 and 2025 at DIAVERUM Montereau, dialysis Unit, France. Baseline demographics and comorbidities (diabetes, hypertension, cardiovascular disease) were collected. Access type at initiation (AVF or CVC) and all access-related complications were recorded over 12 months. Events were categorized as infection (catheter-related bloodstream infection, CRBSI), thrombosis, stenosis, or mechanical dysfunction.

Of 100 patients, 68 had AVFs and 32 had CVCs. Mean age was 75.5 ± 10.7 years; 52% were male, 60% had diabetes, and 90% had hypertension. During 12 months, 42 patients (42%) experienced at least one complication, occurring more frequently in CVC users (93.8%) than AVF users (17.6%). CVC complications included mechanical dysfunction (n = 25) and CRBSI (n = 5). AVF complications comprised stenosis (n = 7) and thrombosis (n = 5); no infections or mechanical events were recorded in the AVF group.

Central venous catheters were associated with substantially higher complication rates than arteriovenous fistulas, primarily mechanical dysfunction and infection. AVF complications were dominated by stenosis and thrombosis. Early AVF creation, reduction of catheter dependence, and vigilant monitoring for stenosis are essential to optimize vascular access outcomes.

Kewords